Literature DB >> 21968005

Accelerometry is associated with walking mobility, not physical activity, in persons with multiple sclerosis.

Madeline Weikert1, Yoojin Suh, Abbi Lane, Brian Sandroff, Deirdre Dlugonski, Bo Fernhall, Robert W Motl.   

Abstract

Accelerometers are seemingly a criterion standard of real-life walking mobility and this is supported by assumptions and empirical data. This application would be strengthened by including objective measures of walking mobility along with a matched control sample for verifying specificity versus generality in accelerometer output. We compared associations among accelerometer output, walking mobility, and physical activity between persons with multiple sclerosis (MS) and controls without a neurological disorder. Sixty-six persons (33 MS, 33 matched controls) completed a battery of questionnaires, performed the six-minute walk (6MW) and timed-up-and-go (TUG), and wore an accelerometer for a 7-day period. After this period, participants completed the Godin Leisure-Time Exercise Questionnaire (GLTEQ) and International Physical Activity Questionnaire (IPAQ). Accelerometer output was significantly correlated with only mobility measures (6MW, ρ=.78; TUG, ρ=-.68) in MS, whereas it correlated with both mobility (6MW, ρ=.58; TUG, ρ=-.49) and physical activity (GLTEQ, ρ=.56; IPAQ, ρ=.53) measures in controls. Regression analysis indicated that only 6MW explained variance in accelerometer output in MS (β=.65, R(2)=.43). These findings support the possibility that accelerometers primarily and specifically measure real-life walking mobility, not physical activity, in persons with MS.
Copyright © 2011 IPEM. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21968005     DOI: 10.1016/j.medengphy.2011.09.005

Source DB:  PubMed          Journal:  Med Eng Phys        ISSN: 1350-4533            Impact factor:   2.242


  16 in total

Review 1.  Motion sensors in multiple sclerosis: Narrative review and update of applications.

Authors:  Jeffer Eidi Sasaki; Brian Sandroff; Marcas Bamman; Robert W Motl
Journal:  Expert Rev Med Devices       Date:  2017-10-18       Impact factor: 3.166

Review 2.  Novel methods and technologies for 21st-century clinical trials: a review.

Authors:  E Ray Dorsey; Charles Venuto; Vinayak Venkataraman; Denzil A Harris; Karl Kieburtz
Journal:  JAMA Neurol       Date:  2015-05       Impact factor: 18.302

3.  Real-world walking in multiple sclerosis: Separating capacity from behavior.

Authors:  Matthew M Engelhard; Stephen D Patek; John C Lach; Myla D Goldman
Journal:  Gait Posture       Date:  2017-10-16       Impact factor: 2.840

Review 4.  Wearable biosensors to monitor disability in multiple sclerosis.

Authors:  Michael J Bradshaw; Samantha Farrow; Robert W Motl; Tanuja Chitnis
Journal:  Neurol Clin Pract       Date:  2017-08

5.  Cognitive Processing Speed Impairment Does Not Influence the Construct Validity of Six-Spot Step Test Performance in People With Multiple Sclerosis.

Authors:  Brian M Sandroff; Stephanie L Silveira; Jessica F Baird; Trinh Huynh; Robert W Motl
Journal:  Phys Ther       Date:  2021-02-04

6.  Home-based system for physical activity monitoring in patients with multiple sclerosis (Pilot study).

Authors:  Layal Shammas; Tom Zentek; Birte von Haaren; Stefan Schlesinger; Stefan Hey; Asarnusch Rashid
Journal:  Biomed Eng Online       Date:  2014-02-06       Impact factor: 2.819

Review 7.  Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.

Authors:  Valerie A J Block; Erica Pitsch; Peggy Tahir; Bruce A C Cree; Diane D Allen; Jeffrey M Gelfand
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

8.  Subjective and objective assessment of physical activity in multiple sclerosis and their relation to health-related quality of life.

Authors:  Theresa Krüger; Janina R Behrens; Anuschka Grobelny; Karen Otte; Sebastian Mansow-Model; Bastian Kayser; Judith Bellmann-Strobl; Alexander U Brandt; Friedemann Paul; Tanja Schmitz-Hübsch
Journal:  BMC Neurol       Date:  2017-01-13       Impact factor: 2.474

9.  Impact of Nutritional Intake on Function in People with Mild-to-Moderate Multiple Sclerosis.

Authors:  Lacey Bromley; Peter J Horvath; Susan E Bennett; Bianca Weinstock-Guttman; Andrew D Ray
Journal:  Int J MS Care       Date:  2019 Jan-Feb

Review 10.  Development of a new method for assessing global risk of Alzheimer's disease for use in population health approaches to prevention.

Authors:  Kaarin J Anstey; Nicolas Cherbuin; Pushpani M Herath
Journal:  Prev Sci       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.